Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 113 for “"CD47"”.
-
Discovery of Anti-CD47 Peptides for Cancer Immunotherapy and CD47-mimicking Peptides That Inhibit Phagocytic Clearance of Nanoparticles
… and both phagocytes and natural killer cells. CD47 is overexpressed in various cancers which act as a potent ‘do not eat me’ signal that contributes to immune evasion of cancer cells. Innate checkpoint inhibitors including CD47/SIRPα antagonists, are now being developed as new strategy for …
-
CD47 regulates cellular and metabolic plasticity in glioblastoma
… detection and resist therapeutic interventions. CD47, often referred to as ‘don’t eat me’ protein, plays a key role in facilitating immune evasion of GBM cells. Despite extensive efforts to target CD47 therapeutically, these approaches have shown limited success. My research has revealed a new …
-
Role of CD47 In Red Cell Apoptosis (Eryptosis)
CD47 is a 47-52 kDa membrane spanning glycoprotein, which has 5 known isoforms and is a member of the immunoglobulin superfamily (IgSF). It possesses a large extracellular N-terminal IgV like domain. CD47 acts as a ‘do not eat me’ signal and consequently as a marker of self. Moreover, CD47 is …
-
Characterising CD47 phosphatase signalling in the hypertensive heart
… major cause of heart failure (HF). Activation of CD47 by the matricellular protein, thrombospondin 1 (TSP1), can cause cellular stress by controlling NADPH oxidase 1 (NOX1) expression, which inhibits angiogenesis and promotes endothelial cell (EC) senescence; all mechanisms underpinning cardiac …
-
The thrombospondin-CD47 axis in skeletal fracture biology
… interaction with cluster of differentiation 47 (CD47), a ubiquitously expressed integrin-associated penta-transmembrane protein that also plays an important role in regulation of cell cycle and homeostasis of the immune system. The purpose of this research is to define the spatiotemporal …
-
Inducing neuroblastoma cell death with CD47 and GD2 antibodies
… 50%. Neuroblastoma cells often express GD2 and CD47 surface markers. While therapies targeting these markers primarily work through immune-mediated mechanisms, emerging evidence suggests that anti-GD2 and anti-CD47 treatments can also induce cell death independently of immune cells. This study …
-
Stimulation of Glioblastoma Proliferation by Macrophages Through CD47/SIRPα
… brain tumour with a need for new treatments. CD47 has been shown to be overexpressed on some human cancers and to interact with macrophages but its role in glioblastoma has not yet been fully explored. Here, we identify a novel role for the CD47/SIRPα interaction between glioblastoma and …
-
Cd47+ Exosomes Facilitate Effective Targeting of Oncogenic Kras In Pancreatic Cancer
… as compared to liposomes, which is mediated by CD47, a widely expressed integrin associated transmembrane protein found on exosomes. We also reveal the role of macropinocytosis in aiding the entry of exosomes into oncogenic Ras mutant pancreatic cancer cells. Overall, our results inform on a …
-
Determining CD47 Structure and Discerning Function to Understand Signal Transduction Mechanism
… require binding to cell surface receptor CD47, an ~50 kDa plasma membrane protein with five transmembrane helices and an extracellular immunoglobulin-like domain. CD47 is central to immune evasion and is overexpressed in many cancers where binding to signal regulatory protein-α (SIRPα) on …
-
Anti-CD47 targeting therapy for the treatment of colon and pancreas cancers.
CD47 is a "don't eat me" signal over expressed on cancer cells inhibiting their engulfment by phagocytes. A novel monoclonal antibody, Hu5F9-G4, blocking CD47's interaction with its ligand SIRPα allowed for phagocytosis of colorectal and pancreas tumors by macrophages. In some models, treatment of …
-
Structural characterization of CD47 and STING in complex with the activating nanobody
… proteins and triggering an oligomerization. CD47, the marker of self, is a membrane protein present on the surface of every human cell, making it a “friend” of the host immune system. “Foes”, e.g. cancer cells, often use its power to evade detection and thrive. Such observations lead to …
-
CD47-Expression auf Blutzellen und im Blutplasma bei Autoimmunhämolytischer Anämie und Immunthrombozytopenie
Das ubiquitär exprimierte Oberflächenprotein CD47 hat sich in tierexperimentellen Studien als Phagozytoseinhibitor und potentielles Protein der Selbsttoleranz erwiesen. In Experimenten an Knockout-Mäusen konnte gezeigt werden, dass zielzellgebundenes CD47 in der Lage ist, die Phagozytose von …
-
CD47 BLOCKING IMMUNOSTIMULATORY ANTIBODY CONJUGATES ELICIT ROBUST TUMOR-SPECIFIC IMMUNITY FROM PHAGOCYTIC CELLS
… arm of immunity. As an innate immune checkpoint, CD47 has been shown to be highly expressed by various types of solid and hematologic tumors and to be correlated with aggressive disease and poor patient outcomes. CD47 delivers an inhibitory “don’t eat me” signal to macrophages through SIRP⍺, …
-
Chimeric Thrombomodulin and CD47 proteins synergistically improve the engraftment of islets by mitigating IBMIR
… immunological ligands, Thrombomodulin (TM) and CD47, on the surface of islets to promote islet engraftment by controlling thrombotic/inflammatory reactions associated with an immediate blood-mediated inflammatory response (IBMIR). In chapter 3, syngeneic pancreatic islets are engineered with a …
-
Prevention of relapse of juvenile myelomonocytic leukemia (JMML) by inhibition of immune checkpoint CD47
… polarization, phagocytic function, and CD47-mediated immune evasion in JMML pathogenesis. Analysis of human PTPN11-mutated JMML spleen samples revealed an enrichment of pro-inflammatory M1-like macrophages compared to KRAS-mutated cases and controls. Both human JMML macrophages and …
-
Steigerung der Effektivität antikörperbasierter Immuntherapien bei malignen Erkrankungen durch Blockade der CD47-SIRPα-Interaktion
… zu entkommen. Ein Beispiel hierfür ist CD47, das nach Bindung an den Rezeptor signal regulatory protein alpha, kurz SIRPα, myeloischer Zellen, wie Makrophagen und Neutrophilen, die Immunzellen inhibiert. Im Rahmen der Arbeit wurde gezeigt, dass der Einsatz des CD47-Blockadeantikörpers …
Page 1 of 6